Literature DB >> 23363810

Prostate disease risk factors among a New Zealand cohort.

Nishi Karunasinghe1, Dug Yeo Han, Megan Goudie, Shuoton Zhu, Karen Bishop, Alice Wang, He Duan, Katja Lange, Sarah Ko, Roxanne Medhora, Shiu Theng Kan, Jonathan Masters, Lynnette R Ferguson.   

Abstract

BACKGROUND: Prostate cancer is a leading public health burden worldwide, and in New Zealand it is the most commonly registered cancer and the third leading cause of cancer deaths among males. Genetic variability and its associations with diet, demographic and lifestyle factors could influence the risk of this disease.
METHODS: The single nucleotide polymorphisms (SNPs) within a group of antioxidant genes and related markers were tested between patient and control cohorts, adjusted for significant differences between basic lifestyle and demographic characteristics.
RESULTS: Increasing age, smoking and low serum selenium levels were significantly associated with an increased risk for prostate disease. Alcohol consumption increased the glutathione peroxidase (GPx) activity. A significant reduction in alcohol consumption was recorded with prostate disease. Three SNPs, namely GPx1 rs1050450, SEL15 rs5845 and CAT rs1001179, were significantly associated with prostate disease risk. A cumulative risk of prostate cancer was noted with 6 risk alleles. A lower GPx activity was recorded with prostate disease compared to the controls. However, the GPx1 rs1050450 allele T in association with prostate cancer recorded a significantly higher GPx activity compared to the controls.
CONCLUSIONS: These data point to a possibility of identifying individuals at risk of prostate cancer for better management purposes.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23363810     DOI: 10.1159/000346279

Source DB:  PubMed          Journal:  J Nutrigenet Nutrigenomics        ISSN: 1661-6499


  16 in total

1.  The rs1050450 C > T polymorphism of GPX1 is associated with the risk of bladder but not prostate cancer: evidence from a meta-analysis.

Authors:  Tongyi Men; Xiaoming Zhang; Jiwei Yang; Bin Shen; Xianduo Li; Dongdong Chen; Jianning Wang
Journal:  Tumour Biol       Date:  2013-08-23

2.  The 811 C/T polymorphism in the 3' untranslated region of the selenoprotein 15-kDa (Sep15) gene and breast cancer in Caucasian women.

Authors:  Rafał Watrowski; Dan Cacsire Castillo-Tong; Gerhild Fabjani; Eva Schuster; Michael Fischer; Robert Zeillinger
Journal:  Tumour Biol       Date:  2015-08-12

3.  Genetic Polymorphism of CAT C-262 T and Susceptibility to Breast Cancer, a Case-Control Study and Meta-Analysis of the Literatures.

Authors:  Mostafa Saadat; Shekoofeh Saadat
Journal:  Pathol Oncol Res       Date:  2014-09-25       Impact factor: 3.201

Review 4.  The catalase C-262T gene polymorphism and cancer risk: a systematic review and meta-analysis.

Authors:  Yongchun Shen; Diandian Li; Panwen Tian; Konglong Shen; Jing Zhu; Mei Feng; Chun Wan; Ting Yang; Lei Chen; Fuqiang Wen
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

5.  A pilot study to investigate if New Zealand men with prostate cancer benefit from a Mediterranean-style diet.

Authors:  Sharon Erdrich; Karen S Bishop; Nishi Karunasinghe; Dug Yeo Han; Lynnette R Ferguson
Journal:  PeerJ       Date:  2015-07-02       Impact factor: 2.984

Review 6.  Selenium and chronic diseases: a nutritional genomics perspective.

Authors:  Catherine Méplan
Journal:  Nutrients       Date:  2015-05-15       Impact factor: 5.717

7.  Influence of Gender and SNPs in GPX1 Gene on Biomarkers of Selenium Status in Healthy Brazilians.

Authors:  Janaina L S Donadio; Elvira M Guerra-Shinohara; Marcelo M Rogero; Silvia M F Cozzolino
Journal:  Nutrients       Date:  2016-05-05       Impact factor: 5.717

8.  The Role of Catalase C262T Gene Polymorphism in the Susceptibility and Survival of Cancers.

Authors:  Cheng-Di Wang; Yan Sun; Nan Chen; Lin Huang; Jing-Wen Huang; Min Zhu; Ting Wang; Yu-Lin Ji
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

9.  Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?

Authors:  Nishi Karunasinghe; Yifei Zhu; Dug Yeo Han; Katja Lange; Shuotun Zhu; Alice Wang; Stephanie Ellett; Jonathan Masters; Megan Goudie; Justin Keogh; Benji Benjamin; Michael Holmes; Lynnette R Ferguson
Journal:  BMC Urol       Date:  2016-08-02       Impact factor: 2.264

Review 10.  Selenium for preventing cancer.

Authors:  Marco Vinceti; Tommaso Filippini; Cinzia Del Giovane; Gabriele Dennert; Marcel Zwahlen; Maree Brinkman; Maurice Pa Zeegers; Markus Horneber; Roberto D'Amico; Catherine M Crespi
Journal:  Cochrane Database Syst Rev       Date:  2018-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.